GO:0031953 negative regulation of protein autophosphorylation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031953 describes any process that stops, prevents, or decreases the rate at which a protein phosphorylates its own residues.
• Autophosphorylation is a common mechanism for kinase activation, and its negative regulation is critical for preventing uncontrolled signaling.
• Key negative regulators include protein phosphatases, intramolecular inhibitory domains, and steric constraints that block the active site.
• Dysregulation of autophosphorylation is linked to cancer, immune disorders, and developmental defects.
• CRISPR knockout, point mutation, and knock-in models are essential to dissect the causal role of autophosphorylation sites and their regulators.
• Studying GO:0031953 requires combining phosphoproteomics, live-cell imaging, and functional assays to capture dynamic autophosphorylation events.
Description
Protein autophosphorylation is a self-catalyzed reaction in which a kinase transfers phosphate groups to its own amino acid residues, often leading to conformational changes that modulate activity. This process is central to signal transduction, cell cycle control, and stress responses. However, unchecked autophosphorylation can cause constitutive activation of oncogenic kinases or disrupt normal cellular homeostasis. Therefore, cells have evolved multiple layers of negative regulation to precisely tune the rate and extent of autophosphorylation. GO:0031953, negative regulation of protein autophosphorylation, captures these diverse mechanisms that stop, prevent, or decrease the rate of a protein phosphorylating itself. Understanding this GO term is essential for researchers studying kinase biology, as it provides a framework to identify regulatory nodes that can be targeted therapeutically. Recent studies have revealed that negative regulation can occur through intramolecular interactions, phosphatase recruitment, or localization-dependent changes. For example, the tyrosine 820 residue in mouse Jak3 acts as an intramolecular brake on its own autophosphorylation. Similarly, protein phosphatase 1 can dephosphorylate PAK2 to limit its activity. These examples highlight the importance of GO:0031953 in both normal physiology and disease.
negative regulation of protein autophosphorylation At A Glance
| GO ID | GO:0031953 |
|---|---|
| GO term | negative regulation of protein autophosphorylation |
| Ontology | biological_process |
| Synonym | down regulation of protein amino acid autophosphorylation; down-regulation of protein amino acid autophosphorylation; downregulation of protein amino acid autophosphorylation; inhibition of protein amino acid autophosphorylation; negative regulation of protein amino acid autophosphorylation |
| Major function | Stops, prevents, or decreases the rate of a protein phosphorylating its own residues. |
| Regulatory mechanisms | Includes phosphatase-mediated dephosphorylation, intramolecular inhibitory domains, and localization-dependent effects. |
| Example regulators | Protein phosphatase 1 (PAK2), Jak3 Y820, Prk1p patch localization. |
| Disease relevance | Cancer, immune disorders, and developmental abnormalities. |
| Research methods | Phosphoproteomics, CRISPR knockouts, live-cell imaging. |
What Is GO:0031953?
GO:0031953, negative regulation of protein autophosphorylation, is defined as any process that stops, prevents, or decreases the rate of the phosphorylation by a protein of one or more of its own residues. This biological process encompasses mechanisms such as dephosphorylation by phosphatases, allosteric inhibition, and steric hindrance that reduce autophosphorylation events.
Why Is negative regulation of protein autophosphorylation Important in Cell Biology?
Negative regulation of protein autophosphorylation is a fundamental control mechanism that prevents aberrant kinase activation, which can lead to cancer, autoimmune diseases, and developmental defects. By understanding GO:0031953, researchers can identify new drug targets and design experiments to modulate signaling pathways with precision.
• Prevents constitutive activation of oncogenic kinases such as Jak3 and PAK2.
• Maintains cell cycle checkpoints by regulating Wee1 and Cdc2 kinases.
• Controls plant photoresponses through phytochrome A autophosphorylation.
• Modulates immune signaling by limiting cytokine receptor-associated kinase activity.
• Influences actin cytoskeleton dynamics via Prk1p regulation.
• Affects stress responses, including the ribotoxic stress response.
• Provides targets for therapeutic intervention in cancers and immune disorders.
• Guides CRISPR-based functional studies of kinase regulatory domains.
What Happens During negative regulation of protein autophosphorylation?
Recognition of Autophosphorylation Sites
In simple terms: The cell identifies when a kinase is phosphorylating itself and prepares to stop it.
Negative regulation begins with the detection of autophosphorylation events, often through conformational changes or cofactor binding that expose regulatory domains. For example, in mouse Jak3, tyrosine 820 acts as an intrinsic sensor that, when phosphorylated, recruits inhibitory factors. Similarly, phytochrome A in plants undergoes autophosphorylation that is modulated by light-induced conformational changes.
Recruitment of Negative Regulators
In simple terms: Specific proteins are called in to block or reverse the autophosphorylation.
Once autophosphorylation is detected, negative regulators such as protein phosphatases are recruited to the site. Protein phosphatase 1 can dephosphorylate PAK2 at autophosphorylated residues, thereby reducing its kinase activity. In yeast, patch localization of Prk1p induces autophosphorylation that subsequently inhibits its own activity, illustrating a self-limiting feedback loop.
Inhibition of Kinase Activity
In simple terms: The kinase is switched off or its activity is reduced.
Negative regulators directly inhibit kinase activity by dephosphorylating critical residues or by inducing conformational changes that close the active site. For instance, the nim1/cdr1 mitotic inducer directly inhibits Wee1 kinase by promoting its autophosphorylation, which leads to Wee1 inactivation. This demonstrates that negative regulation can occur through indirect mechanisms that alter autophosphorylation status.
Downstream Signaling Consequences
In simple terms: The reduced autophosphorylation changes what happens next in the cell.
Decreased autophosphorylation alters downstream signaling cascades, affecting processes such as cell cycle progression, immune responses, and stress adaptation. In the ribotoxic stress response, UV-mediated cell death is driven by autophosphorylation-dependent signaling that is tightly regulated. Dysregulation of these steps can lead to pathological outcomes.
Key Genes Involved in GO:0031953 negative regulation of protein autophosphorylation
The following genes and proteins are experimentally validated participants in negative regulation of protein autophosphorylation, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PAK2 | Serine/threonine kinase regulated by autophosphorylation and PP1-mediated dephosphorylation | Cancer, cytoskeletal dynamics |
| JAK3 | Tyrosine kinase with Y820 intramolecular negative regulation | Immune disorders, leukemia |
| WEE1 | Mitotic kinase inhibited by nim1/cdr1 via autophosphorylation | Cell cycle, cancer therapy |
| CDC2 | Cyclin-dependent kinase regulated by phosphorylation and cyclin binding | Cell cycle, cancer |
| PRK1 | Actin-regulating kinase inhibited by patch localization-induced autophosphorylation | Endocytosis, actin organization |
| PHYA | Phytochrome A with autophosphorylation affecting photoresponses | Plant light signaling |
| CPK1 | Tobacco calcium-dependent protein kinase with autophosphorylation affecting substrate affinity | Plant stress signaling |
| PP1 | Protein phosphatase 1 that dephosphorylates PAK2 | Broad phosphatase research |
| NIM1/CDR1 | Mitotic inducer that negatively regulates Wee1 | Cell cycle control |
| JAK3 Y820 | Specific tyrosine residue acting as negative regulatory site | Autoimmune disease models |
| PAK2 cleavage | Caspase 3-cleaved PAK2 is negatively regulated by PP1 | Apoptosis, cancer |
| PhyA | Light-dependent autophosphorylation | Plant photomorphogenesis |
| Prk1p | Yeast kinase with autophosphorylation-dependent inhibition | Fungal cell biology |
| Wee1 autophosphorylation | Autophosphorylation site that modulates activity | Mitotic entry |
| Cdc2 phosphorylation | Regulatory phosphorylation by Wee1 | Cell cycle checkpoints |
| CPK1 autophosphorylation | Affects substrate binding | Plant calcium signaling |
| JAK3 kinase domain | Contains Y820 negative regulatory site | Immunodeficiency |
| PAK2 kinase domain | Autophosphorylation required for activity | Cancer invasion |
How Is negative regulation of protein autophosphorylation Regulated?
Negative regulation of protein autophosphorylation is itself controlled by multiple upstream signals. For example, the ribotoxic stress response triggers autophosphorylation-dependent cell death that is modulated by stress-activated kinases. In plants, light quality regulates phytochrome A autophosphorylation, which in turn affects photoresponses. Protein phosphatases such as PP1 provide a reversible switch by removing phosphate groups from autophosphorylated residues. Additionally, intramolecular interactions, like the Y820 residue in Jak3, can autoinhibit kinase activity in a phosphorylation-dependent manner. These regulatory layers ensure that autophosphorylation is tightly controlled in response to environmental and developmental cues.
negative regulation of protein autophosphorylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PAK2 | Cancer, apoptosis | Knockout and point mutation in cancer cell lines |
| JAK3 | Immune disorders | Knock-in of Y820F mutation in mice |
| WEE1 | Cancer, cell cycle | CRISPR knockout in HeLa cells |
| CDC2 | Cancer, cell cycle | Point mutation of phosphorylation sites |
| PHYA | Plant development | Overexpression in Arabidopsis |
Cancer
Dysregulated autophosphorylation of kinases such as PAK2 and Jak3 can lead to constitutive activation of proliferative and survival pathways. Loss of negative regulation by protein phosphatase 1 on PAK2 has been implicated in tumor progression. Targeting these regulatory mechanisms is a promising therapeutic strategy.
Immune Disorders
Mutations that disrupt the intramolecular negative regulation of Jak3, such as those affecting tyrosine 820, can cause severe combined immunodeficiency or autoimmune conditions. Understanding GO:0031953 helps in designing drugs that restore proper kinase inhibition.
Developmental Defects
Proper regulation of Wee1 and Cdc2 autophosphorylation is essential for cell cycle progression. Defects in these negative regulatory pathways can lead to developmental abnormalities and genomic instability.
Plant Stress Responses
In plants, negative regulation of phytochrome A autophosphorylation affects photomorphogenesis and stress adaptation. This has implications for crop improvement.
From negative regulation of protein autophosphorylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PP1 regulation increase PAK2 autophosphorylation? | PAK2 knockout with PP1 overexpression |
| What is the role of Jak3 Y820 in autoinhibition? | Jak3 Y820F knock-in mice |
| How does Wee1 autophosphorylation affect mitosis? | Wee1 point mutants in cell lines |
| Does Prk1p patch localization control autophosphorylation? | Prk1p-GFP knock-in yeast |
| Can phytochrome A autophosphorylation be modulated by light? | PhyA overexpression in plants |
| Is Cdc2 autophosphorylation required for cell cycle progression? | Cdc2 knockout with rescue mutants |
How to Study the negative regulation of protein autophosphorylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphoproteomics | Global phosphorylation changes | Identify autophosphorylation sites |
| Live-cell imaging | Real-time kinase dynamics | Study localization effects |
| CRISPR knockout screen | Gene function loss | Discover negative regulators |
| In vitro kinase assay | Direct autophosphorylation rate | Validate regulatory mechanisms |
| Western blot with phospho-antibodies | Specific site phosphorylation | Confirm autophosphorylation sites |
| FRET biosensors | Conformational changes | Monitor kinase activation |
| Co-immunoprecipitation | Protein-protein interactions | Identify phosphatase-kinase complexes |
Phosphoproteomics
Mass spectrometry-based phosphoproteomics allows global identification of autophosphorylation sites and their regulation. This method can quantify changes in phosphorylation stoichiometry upon knockout or overexpression of negative regulators.
Live-Cell Imaging
FRET-based biosensors and fluorescently tagged kinases enable real-time monitoring of autophosphorylation dynamics in living cells. This is particularly useful for studying localization-dependent regulation such as Prk1p patch formation.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify novel negative regulators of autophosphorylation. Libraries targeting phosphatases and kinase regulatory domains are especially powerful.
Biochemical Assays
In vitro kinase assays with purified proteins and phospho-specific antibodies provide direct measurement of autophosphorylation rates and the impact of negative regulators.
How CRISPR Can Be Used to Study GO:0031953 negative regulation of protein autophosphorylation
Knockout
CRISPR knockout of negative regulators such as protein phosphatase 1 or Jak3 Y820 region can lead to increased autophosphorylation, providing causal evidence for their role in GO:0031953.
Point Mutation
Introducing point mutations at autophosphorylation sites (e.g., Jak3 Y820F) or in regulatory domains allows precise dissection of their function without altering protein levels.
Knock-in
Knock-in of tagged or mutant versions of kinases (e.g., GFP-Prk1p) enables visualization and tracking of autophosphorylation in live cells.
Overexpression
Overexpression of negative regulators or kinase mutants can suppress autophosphorylation and reverse pathological phenotypes, offering therapeutic insights.
How EDITGENE Supports negative regulation of protein autophosphorylation Research
Researchers studying negative regulation of protein autophosphorylation-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR services to enable such causal studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of protein autophosphorylation research.
Frequently Asked Questions About negative regulation of protein autophosphorylation
What is GO:0031953?
GO:0031953 is the Gene Ontology term for negative regulation of protein autophosphorylation, defined as any process that stops, prevents, or decreases the rate of a protein phosphorylating its own residues.
What genes are involved in negative regulation of protein autophosphorylation?
Key genes include PAK2, JAK3, WEE1, CDC2, PRK1, PHYA, and CPK1, as well as phosphatases like PP1.
How is protein autophosphorylation negatively regulated?
It can be negatively regulated by phosphatases, intramolecular inhibitory domains, and localization-dependent mechanisms.
Why is negative regulation of autophosphorylation important?
It prevents aberrant kinase activation that can lead to cancer, immune disorders, and developmental defects.
What diseases are associated with defective negative regulation of autophosphorylation?
Cancer, immune disorders, and developmental abnormalities are linked to dysregulation of this process.
What experimental models are used to study GO:0031953?
CRISPR knockout, point mutation, knock-in, and overexpression models in cell lines and organisms are commonly used.
How can CRISPR help study negative regulation of autophosphorylation?
CRISPR enables precise knockout, point mutation, and knock-in of regulatory genes to test causality.
What methods measure autophosphorylation?
Phosphoproteomics, in vitro kinase assays, and phospho-specific western blots are standard methods.
Is negative regulation of autophosphorylation reversible?
Yes, phosphatases such as PP1 can reverse autophosphorylation, making the process dynamic and reversible.
What is an example of intramolecular negative regulation?
The tyrosine 820 residue in mouse Jak3 acts as an intramolecular brake on autophosphorylation.
Conclusion
GO:0031953, negative regulation of protein autophosphorylation, is a critical biological process that ensures proper kinase function and prevents pathological signaling. Through diverse mechanisms including phosphatase action, intramolecular inhibition, and localization-dependent effects, cells tightly control autophosphorylation. Dysregulation of this process contributes to cancer, immune disorders, and developmental defects. Advances in CRISPR-based models and phosphoproteomics are accelerating our understanding of these regulatory networks. EDITGENE offers comprehensive services to support researchers in dissecting the causal roles of genes involved in this process.
References
- 1. Sinha NK et al.. 2024. The ribotoxic stress response drives UV-mediated cell death.. Cell 187(14):3652-3670.e40 PMID: 38843833
- 2. Choi DM et al.. 2023. Regulation of Plant Photoresponses by Protein Kinase Activity of Phytochrome A.. Int J Mol Sci 24(3) PMID: 36768431
- 3. Wang J et al.. 2008. Negative regulation of caspase 3-cleaved PAK2 activity by protein phosphatase 1.. Sci China C Life Sci 51(1):1-11 PMID: 18176785
- 4. Sekine Y et al.. 2022. A novel intramolecular negative regulation of mouse Jak3 activity by tyrosine 820.. Int Immunol 34(6):303-312 PMID: 35192696
- 5. Nigg EA et al.. 1992. Regulation of p34cdc2 protein kinase activity by phosphorylation and cyclin binding.. Ciba Found Symp 170:72-84; discussion 84-96 PMID: 1483352
- 6. Huang B et al.. 2009. Negative regulation of the actin-regulating kinase Prk1p by patch localization-induced autophosphorylation.. Traffic 10(1):35-41 PMID: 18939955
- 7. Ito T et al.. 2017. Autophosphorylation Affects Substrate-Binding Affinity of Tobacco Ca(2+)-Dependent Protein Kinase1.. Plant Physiol 174(4):2457-2468 PMID: 28637832
- 8. Coleman TR et al.. 1993. Negative regulation of the wee1 protein kinase by direct action of the nim1/cdr1 mitotic inducer.. Cell 72(6):919-29 PMID: 7681363
